On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
WednesdayJan 18, 2017 1:21 pm

NetworkNewsBreaks – Apricus Biosciences (NASDAQ: APRI) Shares Skyrocket on Approval of Vitaros® in Mexico

Shares of Apricus Biosciences (NASDAQ: APRI) soared more than 153% after the company announced that Mexico has granted Apricus’ commercialization partner, Ferring Pharmaceuticals, market approval for Vitaros®, an on-demand topical cream for erectile dysfunction. Per an agreement between the two companies, Apricus has received a total of $4.5 million in upfront payments from Ferring, in addition to a regulatory milestone payment of $1.6 million. Apricus is eligible to receive up to an additional $28 million in regulatory, launch and sales milestones, plus royalties on future net sales. Ferring is anticipated to launch in Mexico and Argentina during the second quarter…

Continue Reading

TuesdayJan 17, 2017 2:46 pm

NetworkNewsBreaks – Alcobra (NASDAQ: ADHD) Shares Plunge on Disappointing Results of MDX Clinical Trial

Shares of Alcobra (NASDAQ: ADHD) slumped 49% today after the company reported top-line results from MEASURE, its second phase 3 clinical trial for the investigational product Metadoxine Extended Release (MDX) for the treatment of ADHD in adult patients. MDX did not meet the primary endpoint of demonstrating a statistically significant difference from placebo in the change from baseline of the investigator rating of the Conners’ Adult ADHD Rating Scales (CAARS). "We are exceedingly disappointed with these top-line results. In the coming weeks, the Company intends to review the full data set from MEASURE. Consequently, we will evaluate our options and…

Continue Reading

TuesdayJan 17, 2017 12:17 pm

NetworkNewsBreaks – Gevo, Inc. (NASDAQ: GEVO) Receives EPA Pathway Approval for Isobutanol as Advanced Biofuel

Gevo (NASDAQ: GEVO) this morning said it has received EPA approval for the pathway for isobutanol to be an advanced biofuel under the Renewable Fuel Standard Program (RFS). This development presents an opportunity for Gevo to achieve the 50% or greater greenhouse gas emissions reduction needed to claim the advanced D5 Renewable Identification Number (RIN). Gevo’s isobutanol currently generates D6 RINs, and with this approval, it could generate D5 RINs as well, which have historically had greater value in the marketplace. “We are pleased that there is now a route for advanced fuels that provides protein that contributes to the…

Continue Reading

TuesdayJan 17, 2017 12:15 pm

NetworkNewsBreaks – Celsion (NASDAQ: CLSN) Shares Hike on Positive Data from the OVATION Study

Shares of Celsion (NASDAQ: CLSN) are up 37% after the company reported positive data from the fourth cohort of patients in its phase Ib dose escalating clinical trial (the OVATION Study). The study combines GEN-1, the company's IL-12 gene-mediated immunotherapy, with the standard of care for the treatment of newly diagnosed patients with stage III and IV ovarian cancer who will undergo neoadjuvant chemotherapy followed by interval debulking surgery. The study has produced significant results, with no dose limiting toxicities and promising efficacy signals in this difficult to treat cancer. Celsion said it expects to report final data in Q2…

Continue Reading

ThursdayJan 12, 2017 4:05 pm

NetworkNewsBreaks – Ur-Energy, Inc. (NYSE: URG) Posts Operation Rates above Initial Projections, Reliable Cash Flow

Ur-Energy (NYSE MKT: URG) recently posted its operational results for fourth quarter and year-end 2016, also reporting operational highlights and recent developments such as uranium sales for its Lost Creek in-situ recovery (ISR) uranium facility in south-central Wyoming. Contract sales for the fourth quarter from Lost Creek-produced U3O8 totaled 100,000 pounds at an average price of $32.70 per pound, for sales revenues of $3.3 million. For the year, the company had 662,000 pounds of U3O8 under contract at an average price of $47.61. “Our operations in 2016 continued at rates still well above initial projections for this period in Lost…

Continue Reading

ThursdayJan 12, 2017 2:19 pm

NetworkNewsBreaks – Sino-Global (NASDAQ: SINO) Inks Deal with China Ocean Shipping Agency Qingdao Co.

Sino-Global Shipping America (NASDAQ: SINO) this morning said it has entered into a strategic cooperation agreement with China Ocean Shipping Agency Qingdao Company ("COSCO”) in which COSCO will use Sino-Global’s logistics platform to transport its container shipments into U.S. ports in exchange for a percentage of the total amount of each transportation fee. The agreement reinforces the companies’ ongoing partnership and will expand Sino-Global’s presence in the Shandong province, as well as in other regions, through COSCO's relationships with local subsidiaries in the area. "We continue to seek strategic partnerships and joint venture opportunities that will expand the Company's reach…

Continue Reading

WednesdayJan 11, 2017 3:41 pm

NetworkNewsBreaks – Intellipharmaceutics International, Inc. (NASDAQ: IPCI) Forecasts Improved Annual Sales on Launch of Generic Focalin XR®

Intellipharmaceutics’ (NASDAQ: IPCI) is uniquely positioned to operate in the niche market created by the expiration of drug product patents and exclusivity periods. Part of the company’s strategy includes formulating generic products that are bioequivalent to products covered by soon-to-expire or already expired patents. Intellipharmaceutics recently announced that its marketing partner, Par Pharmaceutical (“Par”), has launched its generic Focalin XR® capsules in 25 and 35 mg strengths in the United States. The FDA has approved Par’s abbreviated new drug application (“ANDA”) for its generic Focalin XR capsules in the 5, 10, 15, 20, 25, 30, 35 and 40 mg strengths. As…

Continue Reading

TuesdayJan 10, 2017 2:36 pm

NetworkNewsBreaks – Arcadia Biosciences, Inc. (NASDAQ: RKDA) Receives U.S. FDA GRAS Status for SONOVA® GLA Safflower Oil, Expands Application Options

Arcadia Biosciences (NASDAQ: RKDA) this morning announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s conclusion that its SONOVA® GLA safflower oil is “generally recognized as safe” (GRAS) for use in nutritional beverages and medical foods. The company followed FDA-proposed procedures to establish its SONOVA® GLA (gamma-linolenic acid) safflower oil as GRAS under the intended conditions of use as a nutritional supplement product. “This FDA GRAS notification expands the application options for Arcadia’s SONOVA® GLA safflower oil, opening adjacent markets for our customers in nutritional beverages and medical foods,” president and CEO Raj Ketkar stated in…

Continue Reading

MondayJan 09, 2017 12:58 pm

NetworkNewsBreaks – Medical Marijuana, Inc. (MJNA) Reports Positive Data on CanChew Plus® CBD Gum by AXIM® Biotechnologies, Inc. (AXIM)

Shares of Medical Marijuana (OTC: MJNA) are ticking higher after the company said its major investment company, AXIM® Biotechnologies (OTC: AXIM), received positive pharmacokinetic (PK) data results on its CanChew Plus® CBD Gum, which will be used in upcoming clinical trials as treatment for irritable bowel syndrome (IBS). The single dose study conducted to determine the concentration of CBD in the blood after chewing one CanChew Plus® Gum for 30 minutes showed positive results for the 30 mg dosage. This data will be used to determine the optimal concentration in the IBS patient trial. AXIM aims to provide a pharmaceutical…

Continue Reading

MondayJan 09, 2017 12:54 pm

NetworkNewsBreaks – DryShips, Inc. (NASDAQ: DRYS) Acquires Large Gas Carrier through Option Agreement; Delivery set for June 2017

DryShips (NASDAQ: DRYS) has exercised its first option under a previously announced option agreement to acquire one Very Large Gas Carrier (VLGC) currently under construction at Hyundai Heavy Industries (HHI) for a purchase price of $83.5 million. The VLGC will be employed on a fixed-rate time charter with five years’ firm duration to an oil major; the charterer has options to extend the firm employment period by up to three years. DryShips said it expects the total gross backlog associated with this time charter to be $54.0 million – or $92.7 million including the optional periods – with delivery of…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217